Contact Us
Drug Search Results
More Filters [+]

Tyrothricin

Alternative Names: tyrothricin
Latest Update: 2024-02-27
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Cell Wall Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Belgium | Bosnia | Brazil | Bulgaria | Croatia | Dominican Republic | Ecuador | Egypt | Germany | Greece | Hong Kong | Hungary | India | Ireland | Israel | Italy | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | New Zealand | Pakistan | Peru | Portugal | Romania | Serbia | Switzerland | Taiwan | Ukraine | United Arab Emirates | United Kingdom | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Engelhard Arzneimittel
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tyrothricin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Healthy Volunteers|Injuries/wounds Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2013-001716-30

P2

Completed

Unknown

2014-03-13

2010-020809-33

P2

Completed

Healthy Volunteers|Injuries/wounds Unspecified

2010-10-08

Recent News Events

Date

Type

Title

02/27/2024

PubMed

 Intrinsic Lipid Curvature and Bilayer Elasticity as Regulators of Channel Function: A Comparative Single-Molecule Study.

02/12/2024

PubMed

 Dimeric Tubulin Modifies Mechanical Properties of Lipid Bilayer, as Probed Using Gramicidin A Channel.

01/01/2024

PubMed

 Rational Design of Amphipathic Antimicrobial Peptides with Alternating L-/D-Amino Acids That Form Helical Structures.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions